Industry Research: CNS Trials are in Dire Need of Study Optimization
Scientists and experts have conducted extensive research on protocol optimization and the need to enhance study efficiency, and sponsors are starting to look at their study design strategies.
Clinical Research Shouldn't be a Trial: How Ontario is Competing to be the Best Place to Conduct Clinical Trials
Competitiveness in the field of industry-sponsored clinical research is largely contingent on speed, quality, and cost.
Three Reasons to Integrate a CTMS and EMR
Integrating a CTMS and an EMR can provide many benefits for supporting the health care needs of patients.
Beyond the Body Shop: How CROs Can Stay Relevant in a Saturated Market
For the past few decades, contract research organizations have successfully fulfilled a 'body-shop' role in clinical development...
MCC Metric of the Month Blog: Percentage Budget Variance
Let's look at a valuable cost metric: percent variance from budget.
Quanticate Expands their Global Operations for Biostatistics and Programming in Clinical Trials
Bangalore and North Carolina facilities look to expand staff after the award of two large FSPs
FSPs Spur Quanticate's Expansion
Quanticate is expanding operations in both its Bangalore, India and Research Triangle Park, NC locations.
INC Research, LLC Acquired MEK Consulting
Acquisition provides customers improved access to Middle East and North Africa region as well as Southern Europe
INC Research Further Expands Geographic Footprint with Acquisition of Leading Middle Eastern CRO MEK Consulting
Proven Methodologies Resulting in Effective and Efficient CTA Process
The management and oversight of clinical trials agreement contracts are still handled through spreadsheets or document management systems ill equipped for an efficient CTA lifecycle.
KCR Expands in UK & Germany and Moves on to France
KCR has opened new offices in London and Berlin, and is now turning its attention to France.
Obama Budget Takes Slap at Pharma
Despite a slight boost in funding for the Food and Drug Administration and stronger tax incentives for investment in R&D, significant changes in Medicare drug reimbursement and coverage policies have biopharmaceutical companies up in arms.
Celerion Opens Operations in South Korea at Seoul National University Hospital Clinical Trial Center
Celerion is pleased to announce the expansion of clinical operations to South Korea.
Celerion will expand clinical operations to South Korea.
The Avoca Quality Consortium Announces New Initiatives for 2014
Expanded membership and new process to prequalify providers among 2014 priorities.
Avoca Quality Consortium Expands Membership to Product and Services Providers
The Avoca Quality Consortium announced its key initiatives for 2014.
DIA Exhibitor Form 2014
Proteomics International Partners with inVentiv Health Clinical
EMA's Guido Rasi Receives Leadership Award
EMA's Executive Director, Guido Rasi received the 2014 European Rare Disease Leadership Award 2014.
Proteomics International Signs Agreement with inVentiv Health Clinical
Partnership offers developers full service biosimilar expertise on a global scale
Quintiles' Dennis Gillings to Become World Dementia Envoy
Dennis Gillings, PhD, Executive Chairman of Quintiles, has been appointed the first world dementia envoy.
Novartis Lends Support to Data Transparency Initiative
Novartis has renewed its commitment to clinical trial data transparency
Clinical Research Global Compliance Just Got Easier
Experienced leaders form Provision Research Compliance Services, a joint venture between Schulman Associates IRB, Inc. and Falcon Consulting Group, LLC
The Next Generation of Clinical Trial Performance Measurement
Organizations involved in clinical trials have embraced the idea that they should collect performance measures to assess how well they conduct clinical trials.
505(b)(2) Pathway Fill Important Role in Generic's Future
...a panel discussion was held with CEOs of top generic pharmaceutical companies and key financial analysts.
How to Fix the Protocol Complexity Problem
Would you delay protocol approval by two months if it meant your enrollment and retention would improve and, in turn, positively affect your data quality?
CEOs Say 505(b)(2) Pathway Will Drive Growth in Generic Industry
A panel discussion was held with CEOs of top generic pharmaceutical companies and key financial analysts...
Joint Venture Between Schulman Associates IRB and Falcon Consulting Group
Schulman Associates IRB, Inc. and Falcon Consulting Group, LLC announced they have formed a joint venture
Pharma Chooses Veeva Systems Platform for Move Out of Legacy Platform
Ipsen will be standardizing its content management on Veeva Systems' Veeva Vault
Ipsen Makes Strategic Move to Standardize on Veeva Systems' Cloud-Based Content Management Solution to Increase Agility
Top pharmaceutical company selects Veeva Vault in enterprise initiative to transform IT and empower the business
